Detailed information for compound 1483794

Basic information

Technical information
  • TDR Targets ID: 1483794
  • Name: cyclopropyl-[4-(2,7-dimethyl-5,6,7,8-tetrahyd ro-[1]benzothiolo[3,2-e]pyrimidin-4-yl)pipera zin-1-yl]methanone
  • MW: 370.512 | Formula: C20H26N4OS
  • H donors: 0 H acceptors: 3 LogP: 3.8 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC1CCc2c(C1)sc1c2c(nc(n1)C)N1CCN(CC1)C(=O)C1CC1
  • InChi: 1S/C20H26N4OS/c1-12-3-6-15-16(11-12)26-19-17(15)18(21-13(2)22-19)23-7-9-24(10-8-23)20(25)14-4-5-14/h12,14H,3-11H2,1-2H3
  • InChiKey: KTYYVXHOAFGXSL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • cyclopropyl-[4-(2,7-dimethyl-5,6,7,8-tetrahydrobenzothiopheno[3,2-e]pyrimidin-4-yl)piperazin-1-yl]methanone
  • cyclopropyl-[4-(2,7-dimethyl-5,6,7,8-tetrahydrobenzothiopheno[3,2-e]pyrimidin-4-yl)-1-piperazinyl]methanone
  • Oprea1_542188
  • Oprea1_189241
  • ASN 05019686

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens G protein-coupled receptor 55 Starlite/ChEMBL No references
Homo sapiens cannabinoid receptor 1 (brain) Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii ribonucleoside-diphosphate reductase large chain 0.0119 0.6445 0.5
Entamoeba histolytica hypothetical protein 0.0036 0 0.5
Schistosoma mansoni ribonucleoside-diphosphate reductase alpha subunit 0.0119 0.6445 0.6445
Plasmodium falciparum ribonucleoside-diphosphate reductase large subunit, putative 0.0119 0.6445 0.5
Entamoeba histolytica hypothetical protein 0.0036 0 0.5
Trichomonas vaginalis ribonucleoside-diphosphate reductase alpha chain, putative 0.01 0.4998 0.5
Plasmodium vivax ribonucleoside-diphosphate reductase large chain, putative 0.0119 0.6445 0.5
Echinococcus multilocularis geminin 0.0164 1 1
Echinococcus multilocularis ribonucleoside diphosphate reductase large 0.0119 0.6445 0.6445
Mycobacterium tuberculosis Ribonucleoside-diphosphate reductase (alpha chain) NrdE (ribonucleotide reductase small subunit) (R1F protein) 0.01 0.4998 1
Entamoeba histolytica hypothetical protein 0.0036 0 0.5
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0048 0.0975 0.1513
Leishmania major ribonucleoside-diphosphate reductase large chain, putative 0.0119 0.6445 0.5
Brugia malayi Calcitonin receptor-like protein seb-1 0.0048 0.0975 0.1513
Schistosoma mansoni hypothetical protein 0.0164 1 1
Brugia malayi ribonucleoside-diphosphate reductase large chain, putative 0.0119 0.6445 1
Wolbachia endosymbiont of Brugia malayi ribonucleotide-diphosphate reductase subunit alpha 0.01 0.4998 0.5
Loa Loa (eye worm) ribonucleoside-diphosphate reductase large subunit 0.0119 0.6445 1
Trypanosoma brucei ribonucleoside-diphosphate reductase large chain 0.0119 0.6445 0.5
Schistosoma mansoni hypothetical protein 0.0164 1 1
Entamoeba histolytica hypothetical protein 0.0036 0 0.5
Trypanosoma cruzi ribonucleoside-diphosphate reductase large chain, putative 0.0119 0.6445 0.5
Mycobacterium leprae RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE (ALPHA CHAIN) NRDE (RIBONUCLEOTIDE REDUCTASE SMALL SUBUNIT) (R1F PROTEIN) 0.01 0.4998 0.5
Mycobacterium ulcerans ribonucleotide-diphosphate reductase subunit alpha 0.01 0.4998 0.5
Echinococcus granulosus ribonucleoside diphosphate reductase large 0.0119 0.6445 0.6445
Treponema pallidum ribonucleotide-diphosphate reductase subunit alpha 0.0119 0.6445 0.5
Chlamydia trachomatis ribonucleoside-diphosphate reductase subunit alpha 0.0119 0.6445 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) > 32 uM PUBCHEM_BIOASSAY: SAR analysis of agonists of the Cannabinoid Receptor 1 using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
EC50 (functional) > 32 uM PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
EC50 (functional) > 32 uM PUBCHEM_BIOASSAY: SAR analysis of agonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
IC50 (functional) = 10.6 uM PUBCHEM_BIOASSAY: SAR Analysis of Selective Antagonists of GPR55 using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
IC50 (functional) = 17.9 uM PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 1 using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
IC50 (functional) > 32 uM PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference
IC50 (functional) > 32 uM PUBCHEM_BIOASSAY: SAR analysis of antagonists of the Cannabinoid Receptor 2 using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.